Noninvasive hematocrit assessment for cardiovascular magnetic resonance extracellular volume quantification using a point-of-care device and synthetic derivation

Journal of Cardiovascular Magnetic Resonance

Volumn 20, Issue 1, 2018, Pages

  Robison, Sean ^a   Karur, Gauri Rani ^a   Wald, Rachel M ^a,b   Thavendiranathan, Paaladinesh ^a,b   Crean, Andrew M ^a,b   Hanneman, Kate ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cardiovascular magnetic resonance (CMR); Extracellular volume (ECV); Hematocrit; Noninvasive hemoglobin monitoring; T1 mapping

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; BLAND ALTMAN ANALYSIS; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL RESEARCH; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; EXTRACELLULAR SPACE; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEMATOCRIT; HUMAN; IMAGE ANALYSIS; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; POINT OF CARE TESTING; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; TEST RETEST RELIABILITY; VEIN PUNCTURE; WILCOXON SIGNED RANKS TEST; CASE CONTROL STUDY; CINE MAGNETIC RESONANCE IMAGING; COMPARATIVE STUDY; DEVICES; DIAGNOSTIC IMAGING; EQUIPMENT DESIGN; EVALUATION STUDY; HEART DISEASE; MIDDLE AGED; OBSERVER VARIATION; OXIMETRY; PATHOPHYSIOLOGY; POINT OF CARE SYSTEM; PREDICTIVE VALUE;

ADULT; CASE-CONTROL STUDIES; EQUIPMENT DESIGN; FEMALE; HEART DISEASES; HEMATOCRIT; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; OBSERVER VARIATION; OXIMETRY; POINT-OF-CARE SYSTEMS; POINT-OF-CARE TESTING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 85043782865     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/s12968-018-0443-1     Document Type: Article

References (49)

1. de Meester de Ravenstein C, Bouzin C, Lazam S, Boulif J, Amzulescu M, Melchior J, Pasquet A, Vancraeynest D, Pouleur A-C, Vanoverschelde J-LJ, Gerber BL. Histological validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from modified look-locker imaging (MOLLI) T1 mapping at 3 T. J Cardiovasc Magn Reson. 2015;17:48.
2. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122:138-44.
3. Diao K-Y, Yang Z-G, Xu H-Y, Liu X, Zhang Q, Shi K, Jiang L, Xie L-J, Wen L-Y, Guo Y-K. Histologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis. J Cardiovasc Magn Reson. 2016;18:1407.
4. Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA, Shakesprere J, Kellman P, Shroff SG, Schwartzman DS, Mulukutla SR, Simon MA, Schelbert EB. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation. 2012;126:1206-16.
5. Wong TC, Piehler KM, Kang IA, Kadakkal A, Kellman P, Schwartzman DS, Mulukutla SR, Simon MA, Shroff SG, Kuller LH, Schelbert EB. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J. 2014;35:657-64.
6. Ambale-Venkatesh B, Lima JA, Cardiac MRI. A central prognostic tool in myocardial fibrosis. Nat Rev Cardiol. 2014;12:18-29.
7. Jellis CL, Kwon DH. Myocardial T1 mapping: modalities and clinical applications. Cardiovasc Diagn Ther. 2014;4:126-37.
8. Berkow L, Rotolo S, Mirski E. Continuous noninvasive hemoglobin monitoring during complex spine surgery. Anesth Analg. 2011;113:1396-402.
9. Joseph B, Pandit V, Aziz H, Kulvatunyou N, Zangbar B, Tang A, O' keeffe T, Jehangir Q, Snyder K, Rhee P. Transforming hemoglobin measurement in trauma patients: noninvasive spot check hemoglobin. J Am Coll Surg. 2015;220:93-8.
10. Frasca D, Dahyot-Fizelier C, Catherine K, Levrat Q, Debaene B, Mimoz O. Accuracy of a continuous noninvasive hemoglobin monitor in intensive care unit patients. Crit Care Med. 2011;39:2277-82.
11. Treibel TA, Fontana M, Maestrini V, Castelletti S, Rosmini S, Simpson J, Nasis A, Bhuva AN, Bulluck H, Abdel-Gadir A, White SK, Manisty C, Spottiswoode BS, Wong TC, Piechnik SK, Kellman P, Robson MD, Schelbert EB, Moon JC. Automatic measurement of the myocardial interstitium: synthetic extracellular volume quantification without hematocrit sampling. J Am Coll Cardiol Img. 2016;9:54-63.
12. Bluemke DA, Kawel-Boehm N. Can a MR imaging scanner accurately measure hematocrit to determine ECV fraction? J Am Coll Cardiol Img. 2016;9:64-6.
13. Raucci FJ, Parra DA, Christensen JT, Hernandez LE, Markham LW, Xu M, Slaughter JC, Soslow JH. Synthetic hematocrit derived from the longitudinal relaxation of blood can lead to clinically significant errors in measurement of extracellular volume fraction in pediatric and young adult patients. J Cardiovasc Magn Reson. 2017;19:58.
14. Messroghli DR, Greiser A, Fröhlich M, Dietz R, Schulz-Menger J. Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging. 2007;26:1081-6.
15. Kim S-H, Lilot M, Murphy LS-L, Sidhu KS, Yu Z, Rinehart J, Cannesson M. Accuracy of continuous noninvasive hemoglobin monitoring. Anesth Analg. 2014;119:332-46.
16. Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood. 2006;107:1747-50.
17. Anaemias N. Report of a WHO scientific group. World health organ tech. Ser. 1968;405:5-37.
18. Arheden H, Saeed M, Higgins CB, Gao DW, Bremerich J, Wyttenbach R, Dae MW, Wendland MF. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology. 1999;211:698-708.
19. Neilan TG, Coelho-Filho OR, Shah RV, Abbasi SA, Heydari B, Watanabe E, Chen Y, Mandry D, Pierre-Mongeon F, Blankstein R, Kwong RY, Jerosch-Herold M. Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice. J Am Coll Cardiol Img. 2013;6:672-83.
20. Liu S, Han J, Nacif MS, Jones J, Kawel N. Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials. J Cardiovasc Magn. 2012;14:90.
21. Kellman P, Wilson JR, Xue H, Bandettini WP, Shanbhag SM, Druey KM, Ugander M, Arai AE. Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience. J Cardiovasc Magn Reson. 2012;14:64.
22. Taylor AJ, Salerno M, Dharmakumar R, Jerosch-Herold M. T1 mapping: basic techniques and clinical applications. J Am Coll Cardiol Img. 2016;9:67-81.
23. Miller CA, Naish JH, Bishop P, Coutts G, Clark D, Zhao S, Ray SG, Yonan N, Williams SG, Flett AS, Moon JC, Greiser A, Parker GJM, Schmitt M. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging. 2013;6:373-83.
24. Siepen FAD, Buss SJ, Messroghli D, Andre F, Lossnitzer D, Seitz S, Keller M, Schnabel PA, Giannitsis E, Korosoglou G, Katus HA, Steen H. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging. 2015;16:210-6.
25. Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, Gatehouse PD, Arai AE, Friedrich MG, Neubauer S, Schulz-Menger J, Schelbert EB. Society for Cardiovascular Magnetic Resonance Imaging, cardiovascular magnetic resonance working Group of the European Society of cardiology. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR working Group of the European Society of cardiology consensus statement. J Cardiovasc Magn Reson. 2013;15:92.
26. Gayat E, Aulagnier J, Matthieu E, Boisson M, Fischler M. Non-invasive measurement of hemoglobin: assessment of two different point-of-care technologies. PLoS One. 2012;7:e30065.
27. McMurdy JW, Jay GD, Suner S, Crawford G. Noninvasive optical, electrical, and acoustic methods of total hemoglobin determination. Clin Chem. 2008;54:264-72.
28. Miller RD, Ward TA, Shiboski SC, Cohen NHA. Comparison of three methods of hemoglobin monitoring in patients undergoing spine surgery. Anesth Analg. 2011;112:858-63.
29. Riess ML, Pagel PS. Noninvasively measured hemoglobin concentration reflects arterial hemoglobin concentration before but not after cardiopulmonary bypass in patients undergoing coronary artery or valve surgery. J Cardiothorac Vasc Anesth. 2016;30:1167-71.
30. Hiscock R. Systematic review and meta-analysis of method comparison studies of Masimo pulse co-oximeters (Radical-7™ or Pronto-7™) and HemoCue® absorption spectrometers (B-hemoglobin or 201+) with laboratory haemoglobin estimation. Anaesth Intensive Care. 2015;43:3.
31. DeBarros M, Shawhan R, Bingham J, Sokol K, Izenberg S, Martin M. Assessing serum hemoglobin levels without venipuncture: accuracy and reliability of Pronto-7 noninvasive spot-check device. Amer J Surg. 2015;209:848-55.
32. Erdogan Kayhan G, Colak YZ, Sanli M, Ucar M, Toprak H. Accuracy of non-invasive hemoglobin monitoring by pulse co-oximeter during liver transplantation. Minerva Anestesiol. 2017;83(5):485-92.
33. Shah N, Osea EA, Martinez GJ. Accuracy of noninvasive hemoglobin and invasive point-of-care hemoglobin testing compared with a laboratory analyzer. Int J Lab Hematol. 2013;36:56-61.
34. Vyas KJ, Danz D, Gilman RH, Wise RA, León-Velarde F, Miranda JJ, Checkley W. Noninvasive assessment of excessive Erythrocytosis as a screening method for Chronic Mountain sickness at high altitude. High Alt Med Biol. 2015;16:162-8.
35. Yamaura K, Nanishi N, Higashi M, Hoka S. Effects of thermoregulatory vasoconstriction on pulse hemoglobin measurements using a co-oximeter in patients undergoing surgery. J Clin Anesth. 2014;26:643-7.
36. Khalafallah AA, Chilvers CR, Thomas M, Chilvers CM, Sexton M, Vialle M, Robertson IK. Usefulness of non-invasive spectrophotometric haemoglobin estimation for detecting low haemoglobin levels when compared with a standard laboratory assay for preoperative assessment. Br J Anaesth. 2015;114:669-76.
37. Barth M, Moser E. Proton NMR Relaxation times of human blood samples at 1.5 T and implications for functional MRI. Cell Mol Biol (Noisy-le-grand). 1997;43:783-91.
38. Tadamura E, Hatabu H, Li W, Prasad PV, Edelman RR. Effect of oxygen inhalation on relaxation times in various tissues. J Magn Reson Imaging. 1997;7:220-5.
39. Yilmaz A, Bucciolini M, Longo G, Franciolini F, Ciraolo L, Renzi R. Determination of dependence of spin-lattice relaxation rate in serum upon concentration of added iron by magnetic resonance imaging. Clin Phys Physiol Meas. 1990;11:343-9.
40. Silvennoinen MJ, Kettunen MI, Kauppinen RA. Effects of hematocrit and oxygen saturation level on blood spin-lattice relaxation. Magn Reson Med. 2003;49:568-71.
41. Belardinelli A, Benni M, Tazzari PL, Pagliaro P. Noninvasive methods for haemoglobin screening in prospective blood donors. Vox Sang 16 ed. 2013;105:116-20.
42. Ardin S, Störmer M, Radojska S, Oustianskaia L, Hahn M, Gathof BS. Comparison of three noninvasive methods for hemoglobin screening of blood donors. Transfusion. 2014;55:379-87.
43. Pajares-Herraiz AL, Rodriguez-Gambarte JD, Eguia-Lopez B, Fernandez-Maqueda CT. Coello de Portugal C, Flores-Sanz MDV. A comparative study of three non-invasive Systems for Measurement of hemoglobin with HemoCue system having coulter LH750 as reference value. Hematol Transfus Int J MedCrave Online. 2015;1:1-10.
44. Jones AR, Twedt D, Swaim W, Gottfried E. Diurnal change of blood count analytes in normal subjects. Am J Clin Pathol. 1996;106:723-7.
45. Pocock SJ, Ashby D, Shaper AG, Walker M, Broughton PM. Diurnal variations in serum biochemical and haematological measurements. J Clin Pathol. 1989;42:172-9.
46. Wennesland R, Brown E, Hopper J, Hodges JL, Guttentag OE, Scott KG, Tucker IN, Bradley B. Red cell, plasma and blood volume in healthy men measured by radiochromium (Cr51) cell tagging and hematocrit: influence of age, somatotype and habits of physical activity on the variance after regression of volumes to height and weight combined. J Clin Invest. 1959;38:1065-77.
47. Schumacher YO, Grathwohl D, Barturen JM, Wollenweber M, Heinrich L, Schmid A, Huber G, Haemoglobin KJ. Haematocrit and red blood cell indices in elite cyclists. Are the control values for blood testing valid? Int J Sports Med. 2000;21:380-5.
48. Thirup P. Haematocrit: within-subject and seasonal variation. Sports Med. 2003;33:231-43.
49. Schmidt W, Biermann B, Winchenbach P, Lison S, Böning D. How valid is the determination of hematocrit values to detect blood manipulations? Int J Sports Med. 2000;21:133-8.